临床检验市场，规模，占有率，趋势，产业分析报告:各类型，各最终用途，各地区 - 2025年～2034年的市场预测

根据 Polaris Market Research 的最新研究，预计到 2034 年，临床检测市场规模将达到 2,871.2 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

临床检测是指为评估健康状况、检测异常并指导医疗决策而进行的系统的诊断评估。自动化和数位技术在实验室运作中的日益融合，提高了效率、准确性和周转时间，从而推动了市场扩张。自动化分析仪、人工智慧驱动的数据解读和先进的资讯系统简化了工作流程，减少了人为错误，并提高了诊断的可靠性。这些技术变革改善了患者的治疗效果，并满足了现代医疗保健系统对高通量检测日益增长的需求。

临床检测市场受个人化医疗日益增长的关注所驱动，个人化医疗需要根据患者个体情况量身定制的先进诊断方法。临床检测在识别生物标记、遗传易感性和治疗反应方面发挥核心作用，从而支持标靶治疗。精准医疗的日益普及推动了对常规诊断之外的专业化和广泛检测的需求。这种朝向以患者为中心的解决方案的转变，强化了检测服务对于提供有效和个人化医疗服务的策略性重要性。

临床检验市场报告重点

按类型划分，糖化血红蛋白 (HbA1c) 检测部门市场将在 2024 年占总收入的 16.42%，这得益于糖尿病患病率的上升以及对长期血糖监测日益增长的关注。

按最终用途划分，预计初级临床部门市场的复合年增长率将达到 8.6%，这得益于对即时检测的需求和诊断途径的改善。

受先进基础设施和新诊断技术应用的推动，到2024年，北美将以40.47%的占有率占全球市场主导地位。

受都市化和医疗保健支出成长的推动，预计亚太市场在2025年至2034年间的复合年增长率将达到9.7%。

全球主要市场参与者包括雅培实验室、奥雅纳公司实验室、中生北控生物科技股份有限公司、查尔斯河实验室、费森尤斯医疗、Genoptix公司、Healthscope有限公司、美国实验室控股公司（LabCorp）、默克公司、NeoGenomics实验室、OPKO Health公司、凯杰公司、Quest Diagnostics公司、西门子医疗股份公司、Snos.Snos.Snos.S.A.S.A.Snos.S.

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 临床检验市场洞察

• 临床检验- 产业概要
• 临床检验市场动态
  • 促进因素和机会
    • 临床试验的快速创新
    • 人口老化与目标疾病盛行率上升
  • 阻碍与课题
    • 高昂的程序成本和模糊的监管框架
• 波特五力模型
  • 供应商议价能力（中）
  • 新进入者的威胁（中）
  • 买方议价能力（高）
  • 替代品的威胁（低）
  • 现有企业之间的竞争（高）
• 政治、经济、社会和技术 (PEST) 分析
• COVID-19 影响分析与产业趋势

第5章 临床检验市场评估:各类型

• 简介
• 全血球计数
• HGB/HCT
• 基础代谢面板
• BUN血肌酐检验
• 电解质检验
• HbA1c检验
• 总括的代谢面板
• 肝臟面板
• 肾臟面板
• 脂质面板

第6章 临床检验市场评估:各最终用途

• 简介
• 中央研究所
• 基层诊所

第7章 临床检验市场评估:各地区

• 简介
• 北美
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
  • 奥地利
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 印尼
  • 马来西亚
  • 韩国
• 南美
  • 巴西
  • 墨西哥
• 中东·非洲
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国

第8章 企业简介

• Abbott Laboratories
• ARUP Laboratories
• OPKO Health, Inc.
• NeoGenomics Laboratories, Inc.
• Genoptix, Inc.
• Healthscope Ltd.
• Laboratory Corporation of America Holdings(LabCorp)
• Fresenius Medical Care
• Quest Diagnostics
• Sonic Healthcare
• QIAGEN
• Siemens Healthineers AG
• Merck KgaA
• Tulip Diagnostics(P)Ltd.
• Biosino Bio-Technology and Science Inc.
• Charles River Laboratories

The clinical laboratory tests market size is expected to reach USD 287.12 billion by 2034, according to a new study by Polaris Market Research. The report "Clinical Laboratory Tests Market Share, Size, Trends, Industry Analysis Report: By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Clinical laboratory tests are defined as systematic diagnostic evaluations conducted to assess health status, detect abnormalities, and guide medical decisions. The rising integration of automation and digital technologies in laboratory operations, which enhances efficiency, accuracy, and turnaround times, drives the market expansion. Automated analyzers, AI-driven data interpretation, and advanced informatics systems are streamlining workflows and reducing human errors, making diagnostics more reliable. This technological transformation improves patient outcomes and also addresses the growing demand for high-throughput testing in modern healthcare systems.

The clinical laboratory tests market is driven by the rising focus on personalized medicine, which requires advanced diagnostics tailored to individual patient profiles. Laboratory testing has a central role in identifying biomarkers, genetic predispositions, and treatment responses, thereby supporting targeted therapies. The growing adoption of precision healthcare is fueling demand for specialized and vast tests that go beyond routine diagnostics. This shift towards patient-centric solutions is reinforcing the strategic importance of laboratory services in delivering effective, customized medical care.

Clinical Laboratory Tests Market Report Highlights

In terms of type, the HbA1c tests segment held a 16.42% revenue share in 2024, driven by rising diabetes rates and a growing focus on long-term glucose monitoring.

Based on end use, the primary clinics segment is projected to grow at a robust 8.6% CAGR, driven by demand for point-of-care testing and better diagnostic access.

North America held a dominant 40.47% global market share in 2024, due to its advanced infrastructure and adoption of new diagnostic technologies.

The Asia Pacific market is forecasted to grow at a 9.7% CAGR from 2025 to 2034, driven by urbanization and increasing healthcare spending.

A few global key market players include Abbott Laboratories; ARUP Laboratories; Biosino Bio-Technology and Science Inc.; Charles River Laboratories; Fresenius Medical Care; Genoptix, Inc.; Healthscope Ltd.; Laboratory Corporation of America Holdings (LabCorp); Merck KgaA; NeoGenomics Laboratories, Inc.; OPKO Health, Inc.; QIAGEN; Quest Diagnostics; Siemens Healthineers AG; Sonic Healthcare; and Tulip Diagnostics (P) Ltd.

Polaris Market Research has segmented the market report on the basis of type, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Complete Blood Count

HGB/HCT

Basic Metabolic Panel

BUN Creatinine Tests

Electrolytes Testing

HbA1c Tests

Comprehensive Metabolic Panel

Liver Panel

Renal Panel

Lipid Panel

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Central Laboratories

Primary Clinics

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction

• 1.1 Report Description
  • 1.1.1 Objectives of the Study
  • 1.1.2 Market Scope
  • 1.1.3 Assumptions
• 1.2 Stakeholders

Chapter 2. Executive Summary

Chapter 3. Research Methodology

• 3.1 Overview
  • 3.1.1 Data Mining
• 3.2 Data Sources
  • 3.2.1 Primary Sources
  • 3.2.2 Secondary Sources

Chapter 4. Clinical Laboratory Tests Market Insights

• 4.1 Clinical Laboratory Tests - Industry snapshot
• 4.1 Clinical Laboratory Tests Market Dynamics
  • 4.1.1 Drivers and Opportunities
    • 4.1.1.1 Rapid innovations in the Clinical Laboratory Tests
    • 4.1.1.2 Rising Geriatric Population and Rising Prevalence Of Target Diseases
  • 4.1.2 Restraints and Challenges
    • 4.1.2.1 High Procedure Costs and Presence of Ambiguous Regulatory Framework
• 4.2 Clinical Laboratory Tests Market - Porter's Five Forces
  • 4.2.1 Bargaining Power of Suppliers (Moderate)
  • 4.2.2 Threats of New Entrants: (Moderate)
  • 4.2.3 Bargaining Power of Buyers (High)
  • 4.2.4 Threat of Substitute (Low)
  • 4.2.5 Rivalry among existing firms (High)
• 4.3 Political, Economic, Social, and Technological (PEST) Analysis
• 4.4 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Clinical Laboratory Tests Market Assessment by Type

• 5.1 Introduction
• 5.2 Complete Blood Count
• 5.3 HGB/HCT
• 5.4 Basic Metabolic Panel
• 5.5 BUN Creatinine Tests
• 5.6 Electrolytes Testing
• 5.7 HbA1c Tests
• 5.8 Comprehensive Metabolic Panel
• 5.9 Liver Panel
• 5.10 Renal Panel
• 5.11 Lipid Panel

Chapter 6. Clinical Laboratory Tests Market Assessment by End-Use

• 6.1 Introduction
• 6.2 Central Laboratories
• 6.3 Primary Clinics

Chapter 7. Clinical Laboratory Tests Market Assessment by Region

• 7.1 Introduction
• 7.2 Clinical Laboratory Tests Market - North America
  • 7.2.1 Clinical Laboratory Tests Market - U.S.
  • 7.2.2 Clinical Laboratory Tests Market - Canada
• 7.3 Clinical Laboratory Tests Market - Europe
  • 7.3.1 Clinical Laboratory Tests Market - Germany
  • 7.3.2 Clinical Laboratory Tests Market - UK
  • 7.3.3 Clinical Laboratory Tests Market - France
  • 7.3.4 Clinical Laboratory Tests Market - Italy
  • 7.3.5 Clinical Laboratory Tests Market - Spain
  • 7.3.6 Clinical Laboratory Tests Market - Netherlands
  • 7.3.7 Clinical Laboratory Tests Market - Austria
• 7.4 Clinical Laboratory Tests Market - Asia Pacific
  • 7.4.1 Clinical Laboratory Tests Market - China
  • 7.4.2 Clinical Laboratory Tests Market - India
  • 7.4.3 Clinical Laboratory Tests Market - Japan
  • 7.4.4 Clinical Laboratory Tests Market - Indonesia
  • 7.4.5 Clinical Laboratory Tests Market - Malaysia
  • 7.4.6 Clinical Laboratory Tests Market - South Korea
• 7.5 Clinical Laboratory Tests Market - Latin America
  • 7.5.1 Clinical Laboratory Tests Market - Brazil
  • 7.5.2 Clinical Laboratory Tests Market - Mexico
• 7.6 Clinical Laboratory Tests Market - Middle East & Africa
  • 7.6.1 Clinical Laboratory Tests Market - Saudi Arabia
  • 7.6.2 Clinical Laboratory Tests Market - UAE

Chapter 8. Company Profiles

• 8.1 Abbott Laboratories
  • 8.1.1 Business Overview
  • 8.1.2 Financial Snapshot
  • 8.1.3 Products and Services
  • 8.1.4 Recent Developments
• 8.2 ARUP Laboratories
  • 8.2.1 Business Overview
  • 8.2.2 Products and Services
  • 8.2.3 Recent Developments
• 8.3 OPKO Health, Inc.
  • 8.3.1 Business Overview
  • 8.3.2 Financial Snapshot
  • 8.3.3 Products and Services
  • 8.3.4 Recent Developments
• 8.4 NeoGenomics Laboratories, Inc.
  • 8.4.1 Business Overview
  • 8.4.2 Financial Snapshot
  • 8.4.3 Products and Services
  • 8.4.4 Recent Developments
• 8.5 Genoptix, Inc.
  • 8.5.1 Business Overview
  • 8.5.2 Products and Services
• 8.6 Healthscope Ltd.
  • 8.6.1 Business Overview
  • 8.6.2 Products and Services
• 8.7 Laboratory Corporation of America Holdings (LabCorp)
  • 8.7.1 Business Overview
  • 8.7.2 Financial Snapshot
  • 8.7.3 Products and Services
  • 8.7.4 Recent Developments
• 8.8 Fresenius Medical Care
  • 8.8.1 Business Overview
  • 8.8.2 Financial Snapshot
  • 8.8.3 Products and Services
  • 8.8.4 Recent Developments
• 8.9 Quest Diagnostics
  • 8.9.1 Business Overview
  • 8.9.2 Financial Snapshot
  • 8.9.3 Products and Services
  • 8.9.4 Recent Developments
• 8.10 Sonic Healthcare
  • 8.10.1 Business Overview
  • 8.10.2 Financial Snapshot
  • 8.10.3 Products and Services
• 8.11 QIAGEN
  • 8.11.1 Business Overview
  • 8.11.2 Financial Snapshot
  • 8.11.3 Products and Services
• 8.12 Siemens Healthineers AG
  • 8.12.1 Business Overview
  • 8.12.2 Financial Snapshot
  • 8.12.3 Products and Services
• 8.13 Merck KgaA
  • 8.13.1 Business Overview
  • 8.13.2 Financial Snapshot
  • 8.13.3 Products and Services
• 8.14 Tulip Diagnostics (P) Ltd.
  • 8.14.1 Business Overview
  • 8.14.2 Products and Services
  • 8.14.3 Recent Developments
• 8.15 Biosino Bio-Technology and Science Inc.
  • 8.15.1 Business Overview
  • 8.15.2 Financial Snapshot
  • 8.15.3 Products and Services
• 8.16 Charles River Laboratories
  • 8.16.1 Business Overview
  • 8.16.2 Financial Snapshot
  • 8.16.3 Products and Services

List of Tables

• Table 1 North America diabetes prevalence (national prevalence %), 2024 & 2034
• Table 2 Europe diabetes prevalence (national prevalence %), 2024 & 2034
• Table 3 Asia Pacific diabetes prevalence (national prevalence %), 2024 & 2034
• Table 4 Latin America Diabetes Prevalence (national prevalence %), 2024 & 2034
• Table 5 MEA and Africa diabetes prevalence (national prevalence %), 2024 & 2034
• Table 6 CIS diabetes prevalence (national prevalence %), 2024 & 2034
• Table 7 Global Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 1 Global Clinical Laboratory Tests Market, by Complete Blood Count, 2021 - 2034 (USD Billion)
• Table 2 Global Clinical Laboratory Tests Market, by HGB/HCT, 2021 - 2034 (USD Billion)
• Table 3 Global Clinical Laboratory Tests Market, by Basic Metabolic Panel, 2021 - 2034 (USD Billion)
• Table 4 Global Clinical Laboratory Tests Market, by BUN Creatinine Tests, 2021 - 2034 (USD Billion)
• Table 5 Global Clinical Laboratory Tests Market, by Electrolytes Testing, 2021 - 2034 (USD Billion)
• Table 6 Global Clinical Laboratory Tests Market, by HbA1c Tests, 2021 - 2034 (USD Billion)
• Table 7 Global Clinical Laboratory Tests Market, by Comprehensive Metabolic Panel, 2021 - 2034 (USD Billion)
• Table 8 Global Clinical Laboratory Tests Market, by Liver Panel, 2021 - 2034 (USD Billion)
• Table 9 Global Clinical Laboratory Tests Market, by Renal Panel, 2021 - 2034 (USD Billion)
• Table 10 Global Clinical Laboratory Tests Market, by Lipid Panel, 2021 - 2034 (USD Billion)
• Table 11 Global Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 12 Global Clinical Laboratory Tests Market, by Central Laboratories, 2021 - 2034 (USD Billion)
• Table 13 Global Clinical Laboratory Tests Market, by Primary Clinics, 2021 - 2034 (USD Billion)
• Table 14 Clinical Laboratory Tests Market Assessment, By Geography, 2021 - 2034 (USD Billion)
• Table 15 North America Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 16 North America Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 17 U.S. Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 18 U.S. Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 19 Canada Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 20 Canada Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 21 Europe Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 22 Europe Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 23 Germany Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 24 Germany Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 25 UK Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 26 UK Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 27 France Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 28 France Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 29 Italy Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 30 Italy Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 31 Spain Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 32 Spain Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 33 Netherlands Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 34 Netherlands Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 35 Austria Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 36 Austria Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 37 Asia Pacific Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 38 Asia Pacific Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 39 China Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 40 China Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 41 India Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 42 India Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 43 Japan Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 44 Japan Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 45 Indonesia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 46 Indonesia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 47 Malaysia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 48 Malaysia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 49 South Korea Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 50 South Korea Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 51 Latin America Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 52 Latin America Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 53 Brazil Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 54 Brazil Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 55 Mexico Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 56 Mexico Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 57 Middle East & Africa Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 58 Middle East & Africa Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 59 Saudi Arabia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 60 Saudi Arabia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 61 UAE Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 62 UAE Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)

List of Figures

• Figure 1. Executive Summary
• Figure 2. Research Methodology: Top Down & Bottom-Up Approach
• Figure 3. Market by Geography, 2017 - 2028 (USD Billion)
• Figure 4. Global percentage of population, by age group, 2000 and 2050
• Figure 5. Population over the age of 65 years, by region, 2010 and 2050
• Figure 6. Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
• Figure 7. Current and projected prevalence of diabetes, by geography, 2024 & 2034 (% increase)
• Figure 8. Porter's Five Forces
• Figure 9. Political, Economic, Social, and Technological (PEST) Analysis
• Figure 10. Market by Type
• Figure 11. Global Clinical Laboratory Tests Market, By Type, 2025 & 2034 (USD Billion)
• Figure 12. Market by End-Use
• Figure 13. Global Clinical Laboratory Tests Market, By End-Use, 2025 & 2034 (USD Billion)
• Figure 14. Clinical Laboratory Tests Market Assessment, By Geography, 2025 & 2034 (USD Billion)